Alexandria Real Estate Equities
ARE
#2405
Rank
NZ$13.78 B
Marketcap
NZ$79.16
Share price
-0.71%
Change (1 day)
-11.61%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -NZ$1.68 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are NZ$2.67 Billion. In 2025 the company made an earning of -NZ$1.81 Billion a decrease over its 2024 earnings that were of NZ$1.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.68 Billion-6.82%
2025 -NZ$1.81 Billion-242.13%
2024 NZ$1.26 B96.11%
2023 NZ$0.64 B-53.56%
2022 NZ$1.39 B-3.96%
2021 NZ$1.44 B-20.26%
2020 NZ$1.81 B72.88%
2019 NZ$1.05 B3.11%
2018 NZ$1.01 B73.54%
2017 NZ$0.58 B464.88%
2016 NZ$0.10 B-77.32%
2015 NZ$0.45 B36.31%
2014 NZ$0.33 B-10.81%
2013 NZ$0.37 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.67 B-825.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.23 B-3,719.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.09 B-1,250.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$4.61 Billion 163.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.03 B-216.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.60 B-1,279.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.22 B-227.16%๐Ÿ‡บ๐Ÿ‡ธ USA